Implantation of Fetal Tissue for the Management of Parkinson??s Disease
- 1 May 1995
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 36 (5)
- https://doi.org/10.1097/00006123-199505000-00027
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by 1-Methyl-4-Phenyl-L,2,3,6-Tetrahydropyridine (MPTP)New England Journal of Medicine, 1992
- Survival of Implanted Fetal Dopamine Cells and Neurologic Improvement 12 to 46 Months after Transplantation for Parkinson's DiseaseNew England Journal of Medicine, 1992
- Unilateral Transplantation of Human Fetal Mesencephalic Tissue into the Caudate Nucleus of Patients with Parkinson's DiseaseNew England Journal of Medicine, 1992
- Transplantation of Human Fetal Dopamine Cells for Parkinson's DiseaseArchives of Neurology, 1990
- Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's DiseaseScience, 1990
- The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonismJournal of Neurosurgery, 1990
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervationNeuroscience Letters, 1986
- FETAL NEURONAL GRAFTS IN MONKEYS GIVEN METHYLPHENYLTETRAHYDROPYRIDINEThe Lancet, 1986
- Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplantsBrain Research, 1979